Literature DB >> 17074860

p38 mitogen-activated protein kinase controls NF-kappaB transcriptional activation and tumor necrosis factor alpha production through RelA phosphorylation mediated by mitogen- and stress-activated protein kinase 1 in response to Borrelia burgdorferi antigens.

Chris M Olson1, Michael N Hedrick, Hooman Izadi, Tonya C Bates, Elias R Olivera, Juan Anguita.   

Abstract

The interaction of Borrelia burgdorferi, the causative agent of Lyme borreliosis, with phagocytic cells induces the activation of NF-kappaB and the expression of proinflammatory cytokines including tumor necrosis factor alpha (TNF-alpha). B. burgdorferi-induced TNF-alpha production is also dependent on the activation of p38 mitogen-activated protein (MAP) kinase. The specific contribution of these signaling pathways to the response of phagocytic cells to the spirochete and the molecular mechanisms underlying this response remain unresolved. We now show that p38 MAP kinase activity regulates the transcriptional activation of NF-kappaB in response to spirochetal lysate stimulation of phagocytic cells. The regulation occurs at the nuclear level and is independent of the translocation of the transcription factor to the nucleus or its capacity to bind to specific DNA target sequences. In RAW264.7 cells, p38alpha MAP kinase regulates the phosphorylation of NF-kappaB RelA. p38 MAP kinase phosphorylates the nuclear kinase mitogen- and stress-activated protein kinase 1 (MSK1). MSK1 in turn phosphorylates the transcriptionally active subunit of NF-kappaB, RelA. The repression of MSK1 expression with small interfering RNA results in reduced RelA phosphorylation and a significant decrease in the production of TNF-alpha in response to B. burgdorferi lysates. Overall, these results clarify the contribution of the signaling pathways that are activated in response to the interaction of spirochetes with phagocytic cells to TNF-alpha production. Our results situate p38 MAP kinase activity as a central regulator of the phagocytic proinflammatory response through MSK1-mediated transcriptional activation of the transcription factor NF-kappaB.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17074860      PMCID: PMC1828394          DOI: 10.1128/IAI.01412-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  56 in total

Review 1.  The p38 signal transduction pathway: activation and function.

Authors:  K Ono; J Han
Journal:  Cell Signal       Date:  2000-01       Impact factor: 4.315

Review 2.  Lyme disease.

Authors:  R M Van Solingen; J Evans
Journal:  Curr Opin Rheumatol       Date:  2001-07       Impact factor: 5.006

3.  Effects of climate on variability in Lyme disease incidence in the northeastern United States.

Authors:  Susan Subak
Journal:  Am J Epidemiol       Date:  2003-03-15       Impact factor: 4.897

4.  Toll-like receptor 2 plays a pivotal role in host defense and inflammatory response to Borrelia burgdorferi.

Authors:  R Mark Wooten; Ying Ma; R Alyson Yoder; Jeanette P Brown; John H Weis; James F Zachary; Carsten J Kirschning; Janis J Weis
Journal:  Vector Borne Zoonotic Dis       Date:  2002       Impact factor: 2.133

5.  Toll-like receptor 2 is required for innate, but not acquired, host defense to Borrelia burgdorferi.

Authors:  R Mark Wooten; Ying Ma; R Alyson Yoder; Jeanette P Brown; John H Weis; James F Zachary; Carsten J Kirschning; Janis J Weis
Journal:  J Immunol       Date:  2002-01-01       Impact factor: 5.422

6.  Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1).

Authors:  Linda Vermeulen; Gert De Wilde; Petra Van Damme; Wim Vanden Berghe; Guy Haegeman
Journal:  EMBO J       Date:  2003-03-17       Impact factor: 11.598

7.  Enhancers and transcription factors controlling the inducibility of the tumor necrosis factor-alpha promoter in primary macrophages.

Authors:  C Drouet; A N Shakhov; C V Jongeneel
Journal:  J Immunol       Date:  1991-09-01       Impact factor: 5.422

Review 8.  Autoimmune mechanisms in antibiotic treatment-resistant lyme arthritis.

Authors:  A C Steere; D Gross; A L Meyer; B T Huber
Journal:  J Autoimmun       Date:  2001-05       Impact factor: 7.094

9.  Induction of COX-2 by LPS in macrophages is regulated by Tpl2-dependent CREB activation signals.

Authors:  Aristides G Eliopoulos; Calin D Dumitru; Chun-Chi Wang; Jeonghee Cho; Philip N Tsichlis
Journal:  EMBO J       Date:  2002-09-16       Impact factor: 11.598

10.  Murine Lyme arthritis development mediated by p38 mitogen-activated protein kinase activity.

Authors:  Juan Anguita; Stephen W Barthold; Rafal Persinski; Michael N Hedrick; Christy A Huy; Roger J Davis; Richard A Flavell; Erol Fikrig
Journal:  J Immunol       Date:  2002-06-15       Impact factor: 5.422

View more
  63 in total

1.  Phosphothreonine Lyase Promotes p65 Degradation in a Mitogen-Activated Protein Kinase/Mitogen- and Stress-Activated Protein Kinase 1-Dependent Manner.

Authors:  Mingyu Hou; Wenhui Wang; Feizi Hu; Yuanxing Zhang; Dahai Yang; Qin Liu
Journal:  Infect Immun       Date:  2018-12-19       Impact factor: 3.441

2.  Macrophage p38 mitogen-activated protein kinase activity regulates invariant natural killer T-cell responses during Borrelia burgdorferi infection.

Authors:  Kelly Hawley; Nicolás Navasa; Chris M Olson; Tonya C Bates; Renu Garg; Michael N Hedrick; Dietrich Conze; Mercedes Rincón; Juan Anguita
Journal:  J Infect Dis       Date:  2012-05-02       Impact factor: 5.226

3.  Epigenome-wide association study reveals longitudinally stable DNA methylation differences in CD4+ T cells from children with IgE-mediated food allergy.

Authors:  David Martino; Jihoon E Joo; Alexandra Sexton-Oates; Thanh Dang; Katrina Allen; Richard Saffery; Susan Prescott
Journal:  Epigenetics       Date:  2014-04-24       Impact factor: 4.528

4.  Mouse Bone Marrow Sca-1+ CD44+ Mesenchymal Stem Cells Kill Avirulent Mycobacteria but Not Mycobacterium tuberculosis through Modulation of Cathelicidin Expression via the p38 Mitogen-Activated Protein Kinase-Dependent Pathway.

Authors:  Sumanta Kumar Naik; Avinash Padhi; Geetanjali Ganguli; Srabasti Sengupta; Sanghamitra Pati; Dasarathi Das; Avinash Sonawane
Journal:  Infect Immun       Date:  2017-09-20       Impact factor: 3.441

5.  The MEK/ERK pathway is the primary conduit for Borrelia burgdorferi-induced inflammation and P53-mediated apoptosis in oligodendrocytes.

Authors:  Geetha Parthasarathy; Mario T Philipp
Journal:  Apoptosis       Date:  2014-01       Impact factor: 4.677

6.  Norisoboldine inhibits the production of pro-inflammatory cytokines in lipopolysaccharide-stimulated RAW 264.7 cells by down-regulating the activation of MAPKs but not NF-κB.

Authors:  Yubin Luo; Mei Liu; Yue Dai; Xiujuan Yao; Yufeng Xia; Guixin Chou; Zhengtao Wang
Journal:  Inflammation       Date:  2010-12       Impact factor: 4.092

Review 7.  IL-32θ: a recently identified anti-inflammatory variant of IL-32 and its preventive role in various disorders and tumor suppressor activity.

Authors:  Muhammad Babar Khawar; Maryam Mukhtar; Muddasir Hassan Abbasi; Nadeem Sheikh
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

8.  Piceatannol inhibits MMP-9-dependent invasion of tumor necrosis factor-α-stimulated DU145 cells by suppressing the Akt-mediated nuclear factor-κB pathway.

Authors:  Rajapaksha Gendara Prasad Tharanga Jayasooriya; Yong-Gab Lee; Chang-Hee Kang; Kyoung-Tae Lee; Yung Hyun Choi; Sung-Yong Park; Jae-Kwan Hwang; Gi-Young Kim
Journal:  Oncol Lett       Date:  2012-10-12       Impact factor: 2.967

9.  CD14 signaling restrains chronic inflammation through induction of p38-MAPK/SOCS-dependent tolerance.

Authors:  Bikash Sahay; Rebeca L Patsey; Christian H Eggers; Juan C Salazar; Justin D Radolf; Timothy J Sellati
Journal:  PLoS Pathog       Date:  2009-12-11       Impact factor: 6.823

Review 10.  The p38alpha mitogen-activated protein kinase as a central nervous system drug discovery target.

Authors:  Aaron S Borders; Lucia de Almeida; Linda J Van Eldik; D Martin Watterson
Journal:  BMC Neurosci       Date:  2008-12-03       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.